Skin exposure to isocyanates: reasons for concern.

Occupational asthma: etiologies and risk factors. Allergy Asthma Immunol Res (2011) 1.04

Characterization of occupational exposures to cleaning products used for common cleaning tasks--a pilot study of hospital cleaners. Environ Health (2009) 0.95

Pathogenesis and disease mechanisms of occupational asthma. Immunol Allergy Clin North Am (2011) 0.90

Immune sensitization to methylene diphenyl diisocyanate (MDI) resulting from skin exposure: albumin as a carrier protein connecting skin exposure to subsequent respiratory responses. J Occup Med Toxicol (2011) 0.87

Skin exposure and asthma: is there a connection? Proc Am Thorac Soc (2010) 0.87

Toluene diisocyanate (TDI) disposition and co-localization of immune cells in hair follicles. Toxicol Sci (2014) 0.84

Setting Occupational Exposure Limits for Chemical Allergens-Understanding the Challenges. J Occup Environ Hyg (2015) 0.84

Urine 1,6-hexamethylene diamine (HDA) levels among workers exposed to 1,6-hexamethylene diisocyanate (HDI). Ann Occup Hyg (2010) 0.83

Occupational exposure to HDI: progress and challenges in biomarker analysis. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.83

Isocyanates and human health: multistakeholder information needs and research priorities. J Occup Environ Med (2015) 0.80

Skin exposure to aliphatic polyisocyanates in the auto body repair and refinishing industry: III. A personal exposure algorithm. Ann Occup Hyg (2008) 0.80

B-lymphocytes as key players in chemical-induced asthma. PLoS One (2013) 0.79

Prevention guidance for isocyanate-induced asthma using occupational surveillance data. J Occup Environ Hyg (2013) 0.79

Absorption of chemicals through compromised skin. Int Arch Occup Environ Health (2009) 0.77

Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature. PLoS One (2015) 0.77

Isocyanate exposure assessment combining industrial hygiene methods with biomonitoring for end users of orthopedic casting products. Ann Occup Hyg (2013) 0.76

A Role for Regulatory T Cells in a Murine Model of Epicutaneous Toluene Diisocyanate Sensitization. Toxicol Sci (2016) 0.76

Potential Inhibitory Influence of miRNA 210 on Regulatory T Cells during Epicutaneous Chemical Sensitization. Genes (Basel) (2016) 0.75

Isocyanates and work-related asthma: Findings from California, Massachusetts, Michigan, and New Jersey, 1993-2008. Am J Ind Med (2015) 0.75

Residual Isocyanates in Medical Devices and Products: A Qualitative and Quantitative Assessment. Environ Health Insights (2016) 0.75

Analysis of the interrelationship of the pulmonary irritation and elicitation thresholds in rats sensitized with 1,6-hexamethylene diisocyanate (HDI). Inhal Toxicol (2015) 0.75

Sensitization and cross-reactivity patterns of contact allergy to diisocyanates and corresponding amines: investigation of diphenylmethane-4,4'-diisocyanate, diphenylmethane-4,4'-diamine, dicyclohexylmethane-4,4'-diisocyanate, and dicylohexylmethane-4,4'-diamine. Contact Dermatitis (2017) 0.75

Understanding factors that influence protective glove use among automotive spray painters. J Occup Environ Hyg (2014) 0.75

Factors associated with the development of peanut allergy in childhood. N Engl J Med (2003) 7.82

Occupational asthma. Am J Respir Crit Care Med (2005) 2.43

Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med (2005) 2.32

Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect (2003) 1.87

Assessing isocyanate exposures in polyurethane industry sectors using biological and air monitoring methods. Ann Occup Hyg (2006) 1.51

Allergic contact dermatitis from 1,6-diisocyanatohexane in an anti-pill finish. Contact Dermatitis (1991) 1.43

Isocyanates in flexible polyurethane foams. Bull Environ Contam Toxicol (2003) 1.42

Respiratory and other hazards of isocyanates. Int Arch Occup Environ Health (1994) 1.36

Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am J Respir Crit Care Med (2000) 1.32

Pulmonary and immunologic evaluation of foundry workers exposed to methylene diphenyldiisocyanate (MDI). J Allergy Clin Immunol (1988) 1.29

Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate. Chest (2000) 1.24

Polyisocyanates in occupational environments: a critical review of exposure limits and metrics. Am J Ind Med (2004) 1.24

Isocyanate vapor-induced antigenicity of human albumin. J Allergy Clin Immunol (2004) 1.24

Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers. Occup Environ Med (2006) 1.23

Overview of diisocyanate occupational asthma. Toxicology (1996) 1.20

Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clin Exp Allergy (2005) 1.17

IL-13 is necessary, not simply sufficient, for epicutaneously induced Th2 responses to soluble protein antigen. J Immunol (2003) 1.16

Dermal contact with toluene diisocyanate (TDI) produces respiratory tract hypersensitivity in guinea pigs. Toxicol Appl Pharmacol (1981) 1.14

Respiratory response to toluene diisocyanate depends on prior frequency and concentration of dermal sensitization in mice. Toxicol Sci (2004) 1.14

The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol (1993) 1.13

A novel mouse model of diisocyanate-induced asthma showing allergic-type inflammation in the lung after inhaled antigen challenge. J Allergy Clin Immunol (2002) 1.11

Induction of respiratory hypersensitivity to diphenylmethane-4,4'-diisocyanate (MDI) in guinea pigs. Influence of route of exposure. Toxicology (1994) 1.09

Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer. J Allergy Clin Immunol (2006) 1.09

Biophysical determinants of toluene diisocyanate antigenicity associated with exposure and asthma. J Allergy Clin Immunol (2006) 1.08

Dermal, inhalation, and internal exposure to 1,6-HDI and its oligomers in car body repair shop workers and industrial spray painters. Occup Environ Med (2006) 1.08

Determinants of isocyanate exposures in auto body repair and refinishing shops. Ann Occup Hyg (2004) 1.06

Asthma caused by diphenylmethane diisocyanate in foundry workers. Clinical, bronchial provocation, and immunologic studies. Am Rev Respir Dis (1983) 1.03

Subclinical immunologic and physiologic responses in hexamethylene diisocyanate-exposed auto body shop workers. Am J Ind Med (2001) 0.96

Isocyanates and respiratory disease: current status. Am J Ind Med (1988) 0.96

Qualitative assessment of isocyanate skin exposure in auto body shops: a pilot study. Am J Ind Med (2000) 0.95

Assessment of the relationship between isocyanate exposure levels and occupational asthma. Am J Ind Med (1997) 0.95

TDI can induce respiratory allergy with Th2-dominated response in mice. Toxicology (2005) 0.95

Exposure to methylene diphenyl diisocyanate in coal mines. Lancet (1993) 0.92

Occupational asthma after exposure to plaster casts containing methylene diphenyl diisocyanate. Occup Med (Lond) (2004) 0.91

Increased sensitivity to toluene diisocyanate (TDI) in airways previously exposed to low doses of TDI. Clin Exp Allergy (1992) 0.91

Isocyanate-conjugated human lung epithelial cell proteins: A link between exposure and asthma? J Allergy Clin Immunol (1999) 0.90

IgG antibodies against polyisocyanates in car painters. Clin Allergy (1988) 0.89

Exposure to 4,4'-methylenediphenyl diisocyanate (MDI) during moulding of rigid polyurethane foam: determination of airborne MDI and urinary 4,4'-methylenedianiline (MDA). Analyst (2001) 0.87

Asthmalike biphasic airway responses in Brown Norway rats sensitized by dermal exposure to dry trimellitic anhydride powder. J Allergy Clin Immunol (2004) 0.87

Tape-strip sampling for measuring dermal exposure to 1,6-hexamethylene diisocyanate. Scand J Work Environ Health (2006) 0.87

Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge. Am J Respir Crit Care Med (1999) 0.86

I are we closer to developing threshold limit values for allergens in the workplace? Ann Allergy Asthma Immunol (2003) 0.86

Slow curing of aliphatic polyisocyanate paints in automotive refinishing: a potential source for skin exposure. J Occup Environ Hyg (2007) 0.85

Percutaneous absorption of organic solvents. Int J Occup Environ Health (2000) 0.85

Isocyanates, polyurethane and childhood asthma. Pediatr Allergy Immunol (2005) 0.84

In vivo skin decontamination of methylene bisphenyl isocyanate (MDI): soap and water ineffective compared to polypropylene glycol, polyglycol-based cleanser, and corn oil. Toxicol Sci (1999) 0.84

Skin decontamination: Importance of the wash-in effect. Food Chem Toxicol (2006) 0.84

Antibodies to toluene diisocyanate in an environmentally exposed population. Environ Health Perspect (1998) 0.83

Poor correlation between stated and found concentrations of diphenylmethane-4,4'-diisocyanate (4,4'-MDI) in petrolatum patch-test preparations. Contact Dermatitis (2004) 0.83

Strategies for the simultaneous collection of vapours and aerosols with emphasis on isocyanate sampling. Analyst (1994) 0.82

Chemical respiratory allergy: role of IgE antibody and relevance of route of exposure. Toxicology (2002) 0.82

Prevention of occupational asthma--practical implications for occupational physicians. Occup Med (Lond) (2005) 0.81

Thresholds in contact sensitization: immunologic mechanisms and experimental evidence in humans--an overview. Food Chem Toxicol (2001) 0.81

Allergic contact dermatitis from dicyclohexylmethane-4,4'-diisocyanate. Contact Dermatitis (2003) 0.80

Clinical findings for residents near a polyurethane foam manufacturing plant. Arch Environ Health (2002) 0.80

An FTIR investigation of isocyanate skin absorption using in vitro guinea pig skin. J Environ Monit (2006) 0.80

Two cases of paraoccupational asthma due to toluene diisocyanate (TDI). Occup Environ Med (2000) 0.80

Does sensitization through the skin occur? Allergy (2000) 0.80

Hazards to health: do it yourself polyurethane foam. Am Rev Respir Dis (1971) 0.80

Occupational allergic contact dermatitis caused by isocyanates. Contact Dermatitis (2002) 0.80

[Asthma caused by methylene-diphenyl-diisocyanate cast in a nurse]. Ugeskr Laeger (2000) 0.79

Skin as a route of exposure to protein allergens. Clin Exp Dermatol (2002) 0.79

Determination of airborne isocyanates generated during the thermal degradation of car paint in body repair shops. Ann Occup Hyg (2006) 0.79

The impact of exposure variables on the induction of skin sensitization. Contact Dermatitis (2006) 0.79

Asthma from diisocyanates is not mediated through a Type IV, patch-test-positive mechanism. Contact Dermatitis (2001) 0.77

Asthma due to non-occupational exposure to toluene (tolylene) di-isocyanate. Clin Allergy (1976) 0.77

Distribution and DNA adduct formation of radiolabeled methylenediphenyl-4,4'-diisocyanate (MDI) in the rat after topical treatment. Toxicol Lett (1997) 0.76

Exposure and nasal inflammation in workers heating polyurethane. Int Arch Occup Environ Health (2002) 0.76

Occupational allergic contact urticaria and asthma from diphenylmethane-4,4'-diisocyanatae. Contact Dermatitis (2003) 0.76

Allergic asthma due to domestic use of insulating polyurethane foam. Lancet (1991) 0.76

Determination of unreacted 2,4-toluene diisocyanate (2,4TDI) and 2,6-toluene diisocyanate (2,6TDI) in foams at ultratrace level by using HPLC-CIS-MS-MS. Analyst (2003) 0.76

Allergic contact dermatitis from aliphatic isocyanate on spectacle frames. Contact Dermatitis (1987) 0.76

Allergic contact dermatitis from 1,6-hexamethylene diisocyanate in a domestic setting. Contact Dermatitis (2003) 0.76

A laboratory investigation of the effectiveness of various skin and surface decontaminants for aliphatic polyisocyanates. J Environ Monit (2005) 0.76

The genome sequence of the malaria mosquito Anopheles gambiae. Science (2002) 20.36

A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science (2002) 9.59

American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol (2012) 7.16

American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol (2009) 6.77

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol (2003) 6.66

Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med (2002) 6.48

American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol (2009) 4.95

Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med (2004) 4.84

American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol (2011) 4.64

American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol (2006) 4.61

Complex glycan catabolism by the human gut microbiota: the Bacteroidetes Sus-like paradigm. J Biol Chem (2009) 4.05

Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2007) 3.91

Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol (2006) 3.71

Early specialty palliative care--translating data in oncology into practice. N Engl J Med (2013) 3.58

The role of chemotherapy at the end of life: "when is enough, enough?". JAMA (2008) 3.31

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. J Clin Oncol (2011) 3.21

Starch catabolism by a prominent human gut symbiont is directed by the recognition of amylose helices. Structure (2008) 3.02

ESTIMATING WELFARE IN INSURANCE MARKETS USING VARIATION IN PRICES. Q J Econ (2010) 2.90

The shortage of essential chemotherapy drugs in the United States. N Engl J Med (2011) 2.74

Palliative care and oncology partnerships in real practice. Oncology (Williston Park) (2011) 2.72

Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2012) 2.62

NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res B Dev Reprod Toxicol (2008) 2.44

Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels. Int J Epidemiol (2012) 2.42

Talking with patients about dying. N Engl J Med (2012) 2.34

Official American Thoracic Society technical standards: spirometry in the occupational setting. Am J Respir Crit Care Med (2014) 2.34

Hospital mortality rates: how is palliative care taken into account? J Pain Symptom Manage (2010) 2.32

Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest (2008) 2.27

The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst (2004) 2.26

MyD88-dependent induction of allergic Th2 responses to intranasal antigen. J Clin Invest (2005) 2.20

Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med (2003) 2.11

Lung cancer in railroad workers exposed to diesel exhaust. Environ Health Perspect (2004) 2.06

Providing pain and palliative care education internationally. J Support Oncol (2011) 2.04

Lung cancer and elemental carbon exposure in trucking industry workers. Environ Health Perspect (2012) 2.04

Efficacy does not necessarily translate to cost effectiveness: a case study in the challenges associated with 21st-century cancer drug pricing. J Clin Oncol (2009) 2.03

Agreement between task-based estimates of the full-shift noise exposure and the full-shift noise dosimetry. Ann Occup Hyg (2009) 1.88

Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control (2003) 1.86

Association between body mass index and acute traumatic workplace injury in hourly manufacturing employees. Am J Epidemiol (2007) 1.85

Is it time for (survivorship care) plan B? J Clin Oncol (2011) 1.84

Residential exposure to petrochemicals and the risk of leukemia: using geographic information system tools to estimate individual-level residential exposure. Am J Epidemiol (2006) 1.84

Cardiovascular diseases and type 2 diabetes in Bangladesh: a systematic review and meta-analysis of studies between 1995 and 2010. BMC Public Health (2012) 1.77

Advances in microbicide vaginal rings. Antiviral Res (2010) 1.76

SPIKE$: a six-step protocol for delivering bad news about the cost of medical care. J Clin Oncol (2008) 1.76

Spatial modeling of PM10 and NO2 in the continental United States, 1985-2000. Environ Health Perspect (2009) 1.73

Fatal Loeffler's endocarditis due to hypereosinophilic syndrome. Am J Hematol (2007) 1.73

The association of particulate air metal concentrations with heart rate variability. Environ Health Perspect (2002) 1.71

Effects of a cost-sharing exemption on use of preventive services at one large employer. Health Aff (Millwood) (2006) 1.69

Contribution of health status and prevalent chronic disease to individual risk for workplace injury in the manufacturing environment. Occup Environ Med (2013) 1.68

Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. J Biol Chem (2010) 1.68

Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J Clin Invest (2002) 1.66

Short-term outcomes in older intensive care unit patients with dementia. Crit Care Med (2005) 1.65

Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase. J Biol Chem (2006) 1.64

Reasons why physicians do not have discussions about poor prognosis, why it matters, and what can be improved. J Clin Oncol (2012) 1.60

Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors. Transplantation (2004) 1.59

Lung cancer and vehicle exhaust in trucking industry workers. Environ Health Perspect (2008) 1.57

Variable response to long-term corticosteroid therapy in chronic beryllium disease. Chest (2004) 1.57

Semen quality, infertility and mortality in the USA. Hum Reprod (2014) 1.56

Improving the quality of cancer care: implications for palliative care. J Palliat Med (2014) 1.49

Structure of antibody-neutralized murine norovirus and unexpected differences from viruslike particles. J Virol (2007) 1.49

Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol (2006) 1.48

Separating deployment-related traumatic brain injury and posttraumatic stress disorder in veterans: preliminary findings from the Veterans Affairs traumatic brain injury screening program. Am J Phys Med Rehabil (2009) 1.47

Association of heart rate variability in taxi drivers with marked changes in particulate air pollution in Beijing in 2008. Environ Health Perspect (2010) 1.45

American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol (2004) 1.44

A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. Int J Radiat Oncol Biol Phys (2005) 1.43

'Futile care': what to do when your patient insists on chemotherapy that likely won't help. Oncology (Williston Park) (2008) 1.42

An official american thoracic society statement: work-exacerbated asthma. Am J Respir Crit Care Med (2011) 1.42

Advance Care Planning Discussions: Why They Should Happen, Why They Don't, and How We Can Facilitate the Process. Oncology (Williston Park) (2015) 1.40

A case of inaccurate prognostication after the ARCTIC protocol. J Pain Symptom Manage (2012) 1.39

The association between personal measurements of environmental exposure to particulates and heart rate variability. Epidemiology (2002) 1.38

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring. Antimicrob Agents Chemother (2011) 1.38

An antibody to the putative aphid recognition site on cucumber mosaic virus recognizes pentons but not hexons. J Virol (2002) 1.35

Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med (2007) 1.35

Differential antifungal and calcium channel-blocking activity among structurally related plant defensins. Plant Physiol (2004) 1.35

Use of employer administrative databases to identify systematic causes of injury in aluminum manufacturing. Am J Ind Med (2007) 1.34

Screening for preexisting cognitive impairment in older intensive care unit patients: use of proxy assessment. J Am Geriatr Soc (2003) 1.32

Work and its role in shaping the social gradient in health. Ann N Y Acad Sci (2010) 1.31

Paradoxes in advance care planning: the complex relationship of oncology patients, their physicians, and advance medical directives. J Clin Oncol (2009) 1.30

Structural determinants of metal specificity in the zinc transport protein ZnuA from synechocystis 6803. J Mol Biol (2003) 1.30

Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial. J Pain Symptom Manage (2011) 1.29

Long-term ambient multipollutant exposures and mortality. Am J Respir Crit Care Med (2010) 1.29

Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States national health and nutrition examination survey. Int J Epidemiol (2013) 1.26

Historical estimation of diesel exhaust exposure in a cohort study of U.S. railroad workers and lung cancer. Cancer Causes Control (2006) 1.26

Polyisocyanates in occupational environments: a critical review of exposure limits and metrics. Am J Ind Med (2004) 1.24

Isocyanate vapor-induced antigenicity of human albumin. J Allergy Clin Immunol (2004) 1.24

TLR4 signaling in stromal cells is critical for the initiation of allergic Th2 responses to inhaled antigen. J Immunol (2010) 1.23

TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis. FASEB J (2013) 1.22

Structural basis for broad detection of genogroup II noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle. J Virol (2012) 1.21

Sex differences in injury patterns among workers in heavy manufacturing. Am J Epidemiol (2008) 1.20

Cause-specific mortality in the unionized U.S. trucking industry. Environ Health Perspect (2007) 1.20

SusG: a unique cell-membrane-associated alpha-amylase from a prominent human gut symbiont targets complex starch molecules. Structure (2010) 1.20

Summary of the findings from the exposure assessments for metalworking fluid mortality and morbidity studies. Appl Occup Environ Hyg (2003) 1.19

High-resolution cryo-electron microscopy structures of murine norovirus 1 and rabbit hemorrhagic disease virus reveal marked flexibility in the receptor binding domains. J Virol (2010) 1.19

Novel inhibitors complexed with glutamate dehydrogenase: allosteric regulation by control of protein dynamics. J Biol Chem (2009) 1.17

An intravaginal ring for the simultaneous delivery of multiple drugs. J Pharm Sci (2012) 1.17

Urinary triclosan is associated with elevated body mass index in NHANES. PLoS One (2013) 1.15

Priorities for development of research methods in occupational cancer. Environ Health Perspect (2003) 1.15

Human rhinovirus capsid dynamics is controlled by canyon flexibility. Virology (2003) 1.14